Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F-positive myeloproliferative neoplasms

被引：15
|
作者：
Kucine, Nicole [1 ]
Al-Kawaaz, Mustafa [2 ]
Hajje, Daher [2 ]
Bussel, James [1 ]
Orazi, Attilio [2 ]
机构：
[1] Weill Cornell Med Coll, Dept Pediat, Div Pediat Hematol Oncol, New York, NY 10065 USA
[2] Weill Cornell Med Coll, Dept Pathol & Lab Med, Div Hematopathol, New York, NY USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 185卷 / 01期
基金：
美国国家卫生研究院;
关键词：
myeloproliferative neoplasm; essential thrombocythaemia; polycythaemia vera; paediatric haematology; TYROSINE KINASE JAK2; MUTATION STATUS; SUBTYPES;
D O I：
10.1111/bjh.15386
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：136 / 139
页数：4
相关论文
共 50 条
  • [1] MINOCA as the first presentation of JAK2 V617F-positive polycythaemia rubra vera
    Rus, M. R. Mohamed
    Suhaimi, A. Mohd
    Zulkufli, M. R.
    Kassim, N. Mohd
    Rozali, N.
    Hussin, F. R.
    Shahril, N. S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 369 : 41 - 41
  • [2] A GERMLINE JAK2 SNP IS ASSOCIATED WITH PREDISPOSITION TO THE DEVELOPMENT OF JAK2 V617F-POSITIVE MYELOPROLIFERATIVE NEOPLASMS
    Kilpivaara, M.
    Mukherjee, S.
    Schram, M.
    Wadleigh, M.
    Mullally, A.
    Ebert, L.
    Bass, A.
    Marubayashi, S.
    Heguy, A.
    Garcia-Manero, G.
    Kantarjian, H.
    Offit, K.
    Stone, M.
    Gilliland, D.
    Klein, J.
    Levine, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 420 - 420
  • [3] The relevance of HLA class II genes in JAK2 V617F-positive myeloproliferative neoplasms
    Shivarov, Velizar
    Tsvetkova, Gergana
    Hadjiev, Evgueniy
    Ivanova, Milena
    HUMAN IMMUNOLOGY, 2023, 84 (03) : 199 - 207
  • [4] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients
    Mayumi Tanaka
    Toshiaki Yujiri
    Shunsuke Ito
    Naoko Okayama
    Toru Takahashi
    Kenji Shinohara
    Yoichi Azuno
    Ryouhei Nawata
    Yuji Hinoda
    Yukio Tanizawa
    International Journal of Hematology, 2013, 97 : 409 - 413
  • [5] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients
    Tanaka, Mayumi
    Yujiri, Toshiaki
    Ito, Shunsuke
    Okayama, Naoko
    Takahashi, Toru
    Shinohara, Kenji
    Azuno, Yoichi
    Nawata, Ryouhei
    Hinoda, Yuji
    Tanizawa, Yukio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (03) : 409 - 413
  • [6] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Brazilian patients
    Macedo, L. C.
    Santos, B. C.
    Pagliarini-E-Silva, S.
    Pagnano, K. B. B.
    Rodrigues, C.
    Quintero, F. C.
    Ferreira, M. E.
    Baraldi, E. C.
    Ambrosio-Albuquerque, E. P.
    Sell, A. M.
    Visentainer, J. E. L.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (05) : 654 - 660
  • [7] JAK2 mutation in polycythaemia vera and essential thrombocythaemia
    Batar, P.
    Kelemen, E.
    Telek, B.
    Remenyi, Gy.
    Kiss, A.
    Rejto, L.
    Udvardy, M.
    BLOOD REVIEWS, 2007, 21 : S123 - S123
  • [8] MECHANISMS DRIVING THROMBOPOIETIN RECEPTOR DOWN MODULATION IN JAK2 V617F-POSITIVE MYELOPROLIFERATIVE NEOPLASMS
    Constantinescu, S.
    Pecquet, C.
    Diaconu, C.
    Staerk, J.
    Girardot, M.
    Royer, Y.
    Defour, J. P.
    Dusa, A.
    Knoops, L.
    Giraudier, S.
    Villeval, J. L.
    Courtoy, P.
    Vainchenker, W.
    HAEMATOLOGICA, 2012, 97 : 372 - 372
  • [9] Systematic analysis of copper, zinc, and selenium levels in JAK2 V617F-positive myeloproliferative neoplasms
    Velizar Shivarov
    Gergana Tsvetkova
    Bisera Atanasova
    Mariana P. Genova
    Irena Ivanova
    Evgueniy Hadjiev
    Milena Ivanova
    Annals of Hematology, 2024, 103 : 2177 - 2179
  • [10] Systematic analysis of copper, zinc, and selenium levels in JAK2 V617F-positive myeloproliferative neoplasms
    Shivarov, Velizar
    Tsvetkova, Gergana
    Atanasova, Bisera
    Genova, Mariana P.
    Ivanova, Irena
    Hadjiev, Evgueniy
    Ivanova, Milena
    ANNALS OF HEMATOLOGY, 2024, 103 (06) : 2177 - 2179
12345